Concepedia

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase

Mariko Nakano, Edward J. Kelly, Allan E. Rettie

Drug Metabolism and Disposition · 2009 · 158 citations · 9 references

DOIFull text

Open access

Concepts

References

9

Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases

James P. Hardwick · Biochemical Pharmacology · 2008 · 323 citations

, , +14

Bietti Crystalline Corneoretinal Dystrophy Is Caused by Mutations in the Novel Gene CYP4V2

Anren Li, Xiaodong Jiao, Francis L. Munier et al. · The American Journal of Human Genetics · 2004 · 288 citations · Full text

, , +7

HET0016, a potent and selective inhibitor of 20‐HETE synthesizing enzyme

Noriyuki Miyata, Kazuo Taniguchi, Takayuki Seki et al. · British Journal of Pharmacology · 2001 · 197 citations · Full text

, , +16

Beneficial Effects of a New 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, TS-011 [N-(3-Chloro-4-morpholin-4-yl) Phenyl-N′-hydroxyimido Formamide], on Hemorrhagic and Ischemic Stroke

Noriyuki Miyata, Takayuki Seki, Yu Tanaka et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 99 citations · Full text

, , +16

Screening for Mutations in CYP4V2 Gene in Japanese Patients With Bietti’s Crystalline Corneoretinal Dystrophy

Yuko Wada, Toshitaka Itabashi, Hajime Sato et al. · American Journal of Ophthalmology · 2005 · 58 citations

, , +5